相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
Sydney C. Yuen et al.
PHARMACOECONOMICS-OPEN (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium
Mihir D. Shanker et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
Liyun Zheng et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Lenvatinib for Hepatocellular Carcinoma: A Literature Review
Takeshi Hatanaka et al.
PHARMACEUTICALS (2021)
Immunotherapy Updates in Advanced Hepatocellular Carcinoma
Amisha Singh et al.
CANCERS (2021)
Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis
Haohao Lu et al.
BMC GASTROENTEROLOGY (2021)
State-of-the-art surgery for hepatocellular carcinoma
Nikolaos Machairas et al.
LANGENBECKS ARCHIVES OF SURGERY (2021)
Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
Rita Golfieri et al.
LIVER CANCER (2021)
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists
Bin-Yan Zhong et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)
Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization
Rohit Agrawal et al.
ANNALS OF GASTROENTEROLOGY (2021)
Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm
Mohamed M. A. Zaitoun et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2021)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Guohong Han et al.
HEPATOLOGY (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Masatoshi Kudo et al.
LIVER CANCER (2020)
TACE combined with microwave a blation therapy vs. TACE alone for treatment of early- and intermediate-stage hepatocellular carcinomas larger than 5 cm: a meta-analysis
Chong Liu et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2020)
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
Wang Yao et al.
FRONTIERS IN ONCOLOGY (2020)
Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve
J. M. Schwartz et al.
CURRENT ONCOLOGY (2020)
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al.
GUT (2020)
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
Weiwen Liu et al.
MEDICAL SCIENCE MONITOR (2020)
Does Drug-Eluting Bead TACE Enhance the Local Effect of IRE? Imaging and Histopathological Evaluation in a Porcine Model
Peter Isfort et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
HCC: Transarterial TherapiesWhat the Interventional Radiologist Can Offer
Thomas J. Vogl et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy
Wooil Kim et al.
ABDOMINAL RADIOLOGY (2019)
Lenvatinib: A Review in Hepatocellular Carcinoma
Zaina T. Al-Salama et al.
DRUGS (2019)
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Amit Mahipal et al.
CANCERS (2019)
The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
Zhentian Xu et al.
ANALYTICAL CELLULAR PATHOLOGY (2019)
The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
Tao Han et al.
BIOSCIENCE TRENDS (2019)
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2019)
Goals and targets for personalized therapy for HCC
Thomas Couri et al.
HEPATOLOGY INTERNATIONAL (2019)
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang et al.
JOURNAL OF HEPATOLOGY (2019)
Irreversible Electroporation in Liver Cancers and Whole Organ Engineering
Aman Saini et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization
Sadahisa Ogasawara et al.
HEPATOLOGY (2018)
Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score
Mark op den Winkel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
Shuichiro Shiina et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis
George N. Ioannou et al.
PLOS ONE (2018)
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
Giorgia Marisi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
Takeshi Hatanaka et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
Haruki Kimura et al.
HEPATOLOGY INTERNATIONAL (2017)
Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Peng Chen et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
XiuPing Zhang et al.
ONCOTARGET (2017)
Loco-regional treatment of HCC: current status
L. Crocetti et al.
CLINICAL RADIOLOGY (2017)
A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma
Mashaal Dhir et al.
ANNALS OF SURGERY (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
Antonio Facciorusso et al.
DIGESTIVE AND LIVER DISEASE (2016)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis
Jing Huai Zou et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatocellular carcinoma: From diagnosis to treatment
Miral Sadaria Grandhi et al.
SURGICAL ONCOLOGY-OXFORD (2016)
Transarterial chemoembolization: Modalities, indication, and patient selection
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2015)
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Xavier Adhoute et al.
JOURNAL OF HEPATOLOGY (2015)
Heat Sink Effect on Tumor Ablation Characteristics as Observed in Monopolar Radiofrequency, Bipolar Radiofrequency, and Microwave, Using Ex Vivo Calf Liver Model
Krishna Pillai et al.
MEDICINE (2015)
Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma
Meredith C. Mason et al.
HPB (2015)
Treatment of Liver Cancer
Chun-Yu Liu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Surgical and Locoregional Therapy of HCC: TACE
Masakatsu Tsurusaki et al.
LIVER CANCER (2015)
A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Sadahisa Ogasawara et al.
PLOS ONE (2015)
Immunotherapy for hepatocellular carcinoma
Shuzhan Li et al.
DRUG DISCOVERIES AND THERAPEUTICS (2015)
How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
Florian Hucke et al.
JOURNAL OF HEPATOLOGY (2014)
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
Ann Lii Cheng et al.
LIVER INTERNATIONAL (2014)
A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma
Xiaofeng Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
L. Kadalayil et al.
ANNALS OF ONCOLOGY (2013)
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
Tong-Chun Xue et al.
BMC GASTROENTEROLOGY (2013)
Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure
Toshiyuki Irie et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
Wolfgang Sieghart et al.
HEPATOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cytokine-induced Killer Cells in Combination With Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Patients
Zhi-Mei Huang et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
Irene Bargellini et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial
Zhen-Wei Peng et al.
RADIOLOGY (2012)
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
Luigi Bolondi et al.
SEMINARS IN LIVER DISEASE (2012)
Percutaneous Tumor Ablation for Hepatocellular Carcinoma
Debra A. Gervais et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
J. -L. Raoul et al.
CANCER TREATMENT REVIEWS (2011)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
分享论文
